VALEO PHARMA ENTERS INTO AN AGREEMENT FOR OPHTHALMIC PRODUCTS, PrXIIDRA® AND PrSIMBRINZA®, IN...
Suspension de la négociation par l'OCRCVM - VPH.WT Canada NewsWire TORONTO, le 25 juill. 2022 TORONTO, le 25 juill. 2022 /CNW/...
IIROC Trading Halt - VPH.WT Canada NewsWire TORONTO, July 25, 2022 TORONTO, July 25, 2022 /CNW/ - The following issues have been halted by...
VALEO PHARMA TO HOST SECOND QUARTER 2022 RESULTS CONFERENCE CALL / WEBCAST Canada NewsWire MONTREAL, June 8...
Valeo Pharma Inc. Opens the Market Canada NewsWire TORONTO, May 9, 2022 TORONTO, May 9, 2022 /CNW/ - Steve Saviuk, Chief Executive Officer...
VALEO PHARMA ANNOUNCES RESULTS OF ANNUAL MEETING OF SHAREHOLDERS, APPOINTMENTS AND OPTIONS AND RSU GRANTS Canada NewsWire MONTREAL, April 28...
VALEO PHARMA TO PRESENT AT THE 2022 BLOOM BURTON & CO HEALTHCARE INVESTOR CONFERENCE Canada...
VALEO PHARMA ANNOUNCES LISTING OF CONVERTIBLE DEBENTURES ON TSX Canada NewsWire MONTREAL, April 19, 2022...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.